This third volume of the series Changing the Global Approach to Medicine explores the programmed command and control functions in a biologic cell. Command and control functions facilitate the intricately organized bio computer systems internal to the cell. Guidance of command and control functions is direct from static intelligence in the human genome. Recognizing all organic life shares similar biologic systems dictates that similar genetics are shared amongst species. A Prime Genome represents all of the fundamental elements and unique portions of the genomes that have ever existed on Earth. The original Prime Genome provided the general instructions necessary to create the various forms of life that have flourished. Ecometabolous is the strategy by which the Prime Genome morphed the elements of a hostile planet into a functional ecosystem with the expected outcome resulting in human form. Also introduced is the concept of the universal component of matter the tritron and sub-sub atomic particle physics, which comprise the essential fabric of the universe.

Volume 1 of the series Changing the Global Approach to Medicine introduced the concept of RNA Vector Therapy, the innovative utilization of virus-like devices to deliver RNA molecules to protein deficient cells to provide a directed medical therapy. Volume 2 greatly expands this approach to configuring enhanced virus-like transport devices to deliver various forms of therapeutic materials to specific cell types. Medial Vector Therapy includes the delivery of DNA, chemotherapy and other drug molecules, oxygen, and nutrients as well as various forms of RNA to the cells that require such therapeutic interventions. This ingenious new approach to the management of challenging diseases has the distinct advantage of administering a broad spectrum of therapeutic elements directly to the cells in need, but dramatically limits the side effects by not exposing other cells in the body to the potential harmful effects of such therapies. Also introduced in this text are the innovative concepts the Quantum Gene and the Quadsistor.

The luminous aether, a concept known for hundreds of years, is the fine essence of the universe. Over the last 130 years, mainstream science abandoned the knowledge such an aether existed. Yet, reawakening the principles of a luminous aether as the fabric of space--both within our being and surrounding us, reaching out in every direction to the very edges of the universe-- explains many unsolved mysteries. The luminous aether is a vast three-dimensional ocean of the tiniest and most elemental particles called quadsitrons. From the fusion of quadsitrons and energy, all else in the universe is constructed. The dynamics of quadsitrons interacting with energy accounts for and connects all the micro and macrophenomena that fill our lives, such as gravity, light, electrons, atoms, molecules, and magnetism. It is essential we understand and grasp the principles of this wondrous quadsitron-energy connectivity in order to advance our technology forward to interstellar travel.

The world is on fire, threatened by a global pandemic brought on by COVID-19. This virulent viral pathogen has rapidly infected every continent across the globe and has spread misery and death in its wake. COVID-19 is very efficient, carrying in its genetic code the instructions to construct its own personal replication machinery. This virus is very effective at copying itself, but does so with a relatively high rate of mutation to the genetic code. Given Coronavirus exhibits a frequent rate of alteration to its state, resulting in an elusive adversary, which makes treating with traditional vaccines an ongoing challenge. Fighting back with novel mRNA therapies, which can be rapidly redesigned, may offer an effective broad-spectrum therapeutic armamentarium to combat Coronavirus. Modification of the native human CD8 cell surface receptor to alert the immune system to the possible presence of the COVID-19, can result in early development of antibodies to target the pathogen. But taking the fight directly to the virus, to stop the infection in an afflicted person, is the next necessary technologic leap in pharmaceutical medicine. Redesigning native human transcription factors to create a hunter-killer protein to neutralize the COVID-19 genome is the next critical innovation necessary to eradicate viral pandemics. Cultivating a cure to counteract viral infections such as Coronavirus is now more essential than ever. Ebola, a devastatingly hostile viral infection, sits lurking, in wait. At the point Ebola evolves into an airborne viral entity, the consequences of such a noxious global pandemic will be horrific. The time is now, to secure versatile and effective vaccines and devise an effective cure to stop rampant viral infections, such as Coronavirus and Ebola.

The world is under constant threat of a virus evolving into a global plague. To this point, there is no direct defense against a widespread viral infection. DNA Vaccines: Design of a Gene to Eradicate HIV offers an innovative and new strategy to combat deadly viral infections. Presented is the discovery of a unique identifier for HIV. Analysis of the transcription and translation mechanisms utilized by cells leads to exploring the function of nuclear transcription factor proteins as intracellular hunter-killer molecules aimed specifically at viral genomes. Utilizing amino acid-to-nucleotide binding characteristics, taking into account Watson-Crick binding, Hoogsteen grove binding, and Vander Waals forces, modifications to existing transcription factors binding sites are undertaken. Transcription factors are altered to specifically target the unique identifier of pathogenic viruses. Binding a transcription factor directly to a viral genome is intended to silence the genome, preventing transcription if embedded in the DNA or interfering with translation if the genome is present in a cells cytoplasm as RNA. This text describes the design of an intracellular courier gene technology to make cells defensible against HIV and other lethal pathogenic viral threats.

The microscopic features of viruses can be thought of in terms of building blocks. Rearranging the building blocks can lead to the development of very effective and precise medical tools. HIV provides a unique educational tool to learn how viruses can be modified to benefit mankind, and in the process rid the world of the threat of AIDS. Diabetes, Obesity, Fatigue and Aging may all be approached in a similar manner, utilizing modified viruses to repair defects in the powerhouses of the cells. This book details 14 patent applications submitted to the US Patent Office since January 2008. These patents applications represent a starkly different approach to medicine and represent means for eradicating the threat of AIDS, curing Diabetes, Obesity, Fatigue, Halting the Aging process and innovative new ways of treating Heart Attacks, Stroke, and Cancer.

The world is under constant threat of a virus evolving into a global plague.To this point, there is no direct defense against a widespread viral infection. Fourth Generation Biologics: Molecular Virus Killers offers an innovative, new strategy to combat deadly viral infections. Presented is the discovery of unique identifiers for the viral scourges: HIV, Herpes Simplex, the Shingles virus, the Smallpox virus and the newly emerging threats of Ebola virus and the Chikungunya virus. Analysis of the transcription and translation mechanisms utilized by cells leads to exploring the function of nuclear signaling proteins as intracellular hunter-killer molecules aimed specifically at viral genomes. Utilizing amino acid-to-nucleotide binding characteristics, taking into account Watson-Crick binding, Hoogsteen grove binding, and Vander Waals forces, modifications to existing transcription factors binding sites is undertaken. Transcription factors are altered to specifically target the unique identifier of pathogenic viruses. Binding a transcription factor directly to a viral genome is intended to silence the genome, preventing transcription if embedded in the DNA or interfering with translation if the genome is present in a cells cytoplasm as RNA. This emerging technology is then extrapolated to explore activating therapeutic nuclear genes to treat challenging medical conditions including diabetes and osteoarthritis.